Secondary Erythrocytosis Among Type 2 Diabetes Mellitus Patients With Hypogonadism Using Sodium‐Glucose Cotransporter 2 Inhibitors and Testosterone Replacement Therapy
SGLT-2i and TRT co-administration are associated with an increased chance of developing secondary erythrocytosis in T2DM. Awareness and potential treatment discontinuation may prevent unnecessary investigations. Frequent monitoring of these parameters is essential.
Authors
- Maharan Kabha (ORCID: https://orcid.org/0009-0007-1227-3515)
- Hilla Cohen
- Yoram Dekel (ORCID: https://orcid.org/0000-0003-1384-0503)
- Adnan Zaina (ORCID: https://orcid.org/0000-0001-7482-3104)
- Sameer Kassem (ORCID: https://orcid.org/0000-0003-3588-0338)
- Hadar Dana
Institutions
- Bar-Ilan University (IL)
- Technion – Israel Institute of Technology (IL)
- Carmel Medical Center (IL)
- Rappaport Family Institute for Research in the Medical Sciences (IL)
- Kerala Institute of Medical Sciences (IN)
- Clalit Health Services (IL)
Publication Details
- Journal
- Endocrinology Diabetes & Metabolism
- Published
- 2025-06-03
- DOI
- https://doi.org/10.1002/edm2.70064
- Citations
- 5
- Primary Topic
- Hormonal and reproductive studies
- Type
- article
- Field-Weighted Citation Impact
- 6.47